3 results
In this study, we look at how safe the new medicinal product XMT-1536 is for the treatment of ovarian cancer and how well it works. We compare the effect of XMT-1536 with the effect of a placebo. A placebo is a product without the active ingredient…
The objectives of this study are to assess and compare at 6 months 1) the percentage of subjects achieving bilateral uncorrected distance visual acuity and bilateral uncorrected near visual acuity <= 0.1 logMar; 2) spectacle independence at…
Primary objective:The objective is to evaluate if the LCPT dose can be reduced in comparison with tacrolimus-ER and still achieve similar tacrolimus levels in the therapeutic range in patients who are tacrolimus who need a relatively high dose of…